Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) PT at $92.50

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been assigned an average recommendation of “Hold” from the fourteen ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $92.50.

A number of brokerages recently commented on GEHC. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Morgan Stanley increased their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Citigroup lifted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Evercore upped their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th.

GE HealthCare Technologies Stock Down 3.7%

GEHC stock opened at $74.27 on Wednesday. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The company has a market cap of $33.85 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 1.69 and a beta of 1.03. The business’s 50-day simple moving average is $81.81 and its 200 day simple moving average is $78.54.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter last year, the company earned $1.45 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts anticipate that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Dodge & Cox boosted its position in GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after buying an additional 389,796 shares in the last quarter. State Street Corp raised its stake in shares of GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock valued at $989,673,000 after acquiring an additional 37,159 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.